Alerts will be sent to your verified email
Verify EmailMAHAREM
|
IndoAmerican Advance
|
Chemkart India
|
Speciality Medicines
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.31 % | 57.15 % | 38.23 % |
|
5yr average Equity Multiplier
|
1.07 | 2.41 | 2.01 |
|
5yr Average Asset Turnover Ratio
|
0.15 | 2.97 | 2.86 |
|
5yr Avg Net Profit Margin
|
-36.65 % | 8.77 % | 9.1 % |
|
Price to Book
|
n/a | 0.0 | 0.0 |
|
P/E
|
n/a | 8.74 | 13.53 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 74.43 Days | 128.49 Days |
|
Inventory Days
|
0.0 | 17.49 Days | 60.0 Days |
|
Days Receivable
|
0.0 | 69.5 Days | 63.56 Days |
|
Days Payable
|
167.71 Days | 31.94 Days | 27.57 Days |
|
5yr Average Interest Coverage Ratio
|
-55.68 | 26.3 | 26.44 |
|
5yr Avg ROCE
|
-12.15 % | 78.81 % | 54.65 % |
|
5yr Avg Operating Profit Margin
|
-72.03 % | 12.11 % | 13.99 % |
|
5 yr average Debt to Equity
|
0.0 | 0.59 | 0.4 |
|
5yr CAGR Net Profit
|
n/a | 34.67 % | 42.22 % |
|
5yr Average Return on Assets
|
-11.02 % | 24.52 % | 18.23 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.97 % | 74.66 % | 43.43 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-17.4 % | 1.35 % | 43.43 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
IndoAmerican Advance
|
Chemkart India
|
Speciality Medicines
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|